EyeGene Inc. (KOSDAQ:185490)

EyeGene Revenue

EyeGene had revenue of 1.27B KRW in the quarter ending March 31, 2026, with 55.55% growth. This brings the company's revenue in the last twelve months to 4.02B, up 10.16% year-over-year. In the year 2025, EyeGene had annual revenue of 3.57B with 6.29% growth.

• Revenue (ttm): 4.02B
• Revenue Growth: +10.16%
• P/S Ratio: 14.47
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 58.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.57B	211.02M	6.29%
Dec 31, 2024	3.36B	230.37M	7.37%
Dec 31, 2023	3.13B	-2.17B	-40.96%
Dec 31, 2022	5.29B	2.05B	63.27%
Dec 31, 2021	3.24B	-121.31M	-3.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error